234 related articles for article (PubMed ID: 33805741)
1. Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-
Silva BR; Rebelo R; Rodrigues JM; Xavier CPR; Vasconcelos MH; Queiroz MRP
Molecules; 2021 Mar; 26(6):. PubMed ID: 33805741
[TBL] [Abstract][Full Text] [Related]
2. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Lima RT; Vasconcelos MH
Eur J Med Chem; 2010 Dec; 45(12):5628-34. PubMed ID: 20926160
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives.
Leung E; Pilkington LI; van Rensburg M; Jeon CY; Song M; Arabshahi HJ; De Zoysa GH; Sarojini V; Denny WA; Reynisson J; Barker D
Bioorg Med Chem; 2016 Mar; 24(5):1142-54. PubMed ID: 26853836
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
5. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Novel Methyl 7-[(Hetero)arylamino]thieno[2,3-
Rodrigues JM; Calhelha RC; Nogueira A; Ferreira ICFR; Barros L; Queiroz MRP
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443411
[TBL] [Abstract][Full Text] [Related]
7. New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death.
Queiroz MJ; Peixoto D; Calhelha RC; Soares P; Dos Santos T; Lima RT; Campos JF; Abreu RM; Ferreira IC; Vasconcelos MH
Eur J Med Chem; 2013 Nov; 69():855-62. PubMed ID: 24121236
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of tumor cell growth inhibition of methyl 3-amino-6-[(hetero)arylethynyl]thieno[3,2-b]pyridine-2-carboxylates. Structure-activity relationships, effects on the cell cycle and apoptosis.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Almeida GM; Vasconcelos MH
Eur J Med Chem; 2011 Jan; 46(1):236-40. PubMed ID: 21138784
[TBL] [Abstract][Full Text] [Related]
10. Aminodi(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, effects in human tumor cells growth, cell cycle analysis, apoptosis and evaluation of toxicity using non-tumor cells.
Calhelha RC; Ferreira IC; Peixoto D; Abreu RM; Vale-Silva LA; Pinto E; Lima RT; Alvelos MI; Vasconcelos MH; Queiroz MJ
Molecules; 2012 Mar; 17(4):3834-43. PubMed ID: 22456543
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
13. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and docking study of pyridine and thieno[2,3-b] pyridine derivatives as anticancer PIM-1 kinase inhibitors.
Abdelaziz ME; El-Miligy MMM; Fahmy SM; Mahran MA; Hazzaa AA
Bioorg Chem; 2018 Oct; 80():674-692. PubMed ID: 30064079
[TBL] [Abstract][Full Text] [Related]
15. Antitumor Effects of Ir(III)-2
Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Molecular Mechanism of Cinnamic Acid-Mediated Cytotoxicity in Triple Negative MDA-MB-231 Breast Cancer Cells.
Pal A; Tapadar P; Pal R
Anticancer Agents Med Chem; 2021; 21(9):1141-1150. PubMed ID: 32767960
[TBL] [Abstract][Full Text] [Related]
17. A styrylpyrone dimer isolated from Aniba heringeri causes apoptosis in MDA-MB-231 triple-negative breast cancer cells.
de Souza KFS; Tófoli D; Pereira IC; Filippin KJ; Guerrero ATG; Paredes-Gamero EJ; de Fatima Cepa Matos M; Garcez WS; Garcez FR; Perdomo RT
Bioorg Med Chem; 2021 Feb; 32():115994. PubMed ID: 33477019
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.
Lei M; Feng H; Bai E; Zhou H; Wang J; Qin Y; Zhang H; Wang X; Liu Z; Hai O; Liu J; Zhu Y
Org Biomol Chem; 2019 Jan; 17(3):683-691. PubMed ID: 30601533
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel feruloyl dipeptides with proapoptotic potential against different cancer cell lines.
Hamed A; Frese M; Elgaafary M; Syrovets T; Sewald N; Simmet T; Shaaban M
Bioorg Chem; 2020 Apr; 97():103678. PubMed ID: 32120076
[TBL] [Abstract][Full Text] [Related]
20. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
